Does a life sciences company with employees need employment practices liability (EPLI) insurance?

Yes - once a life-sciences company has employees, it has employment-practices liability exposure, and that exposure is not covered by general liability, professional liability, or products liability. Employment claims are among the most common lawsuits any employer faces, and they are brought by the company's own people rather than customers or trial subjects, so no amount of clinical, products, or E&O coverage responds to them.

EPLI (employment practices liability insurance) is the line that covers wrongful termination, discrimination, harassment, retaliation, and related employment claims - including defense costs, which are often the larger part of the exposure because even a meritless claim has to be defended.

EPLI responds to claims by employees (and, with the right endorsement, applicants and in some cases third parties) alleging wrongful acts in the employment relationship. The covered allegations typically include wrongful termination, discrimination (age, sex, race, disability, pregnancy, national origin, and other protected classes), sexual and other workplace harassment, retaliation, failure to promote, wrongful discipline, and negligent evaluation.

Coverage is almost always claims-made and pays both defense and settlement/judgment. Wage-and-hour claims (unpaid overtime, employee misclassification) are frequently excluded from the base form and, where available, offered only as a sub-limited defense-cost endorsement - an important gap to check, because wage-and-hour is one of the more common exposures for a fast-scaling technical workforce.

Hiring and layoffs track the capital and clinical calendar. Companies staff up after a raise or a positive readout and restructure after a failed endpoint, a pipeline reprioritization, or a missed milestone. Reductions in force are one of the most reliable triggers of discrimination and wrongful-termination claims, and life-sciences companies run them more often than a stable-headcount business.

The workforce is credentialed, well-advised, and mobile. Scientists, clinical staff, and executives move between competitors, understand their rights, and are more likely to retain counsel over a termination or promotion dispute. Non-compete and trade-secret friction on departure can escalate into retaliation and wrongful-termination allegations.

Operations frequently span states. A company headquartered in Texas with remote staff, a clinical team, or a second site in California, Massachusetts, or New York is subject to several different state employment regimes at once - and states like California carry employee-favorable standards that raise both claim frequency and defense cost.

There are three common structures. (1) A standalone EPLI policy - the most flexible, with the broadest limits and endorsement options, typical for companies past the earliest stage or with meaningful headcount. (2) An EPLI coverage part inside a management-liability (D&O) program - efficient for a venture-backed biotech that is already buying D&O at its first institutional round, since the same management-liability tower can house D&O, EPLI, and fiduciary coverage. (3) An EPLI endorsement on a business owners policy - the entry-level option for a small company whose main policy is a BOP.

For a startup already buying D&O for investors, folding EPLI into the management-liability program is usually the cleanest path. For a small pre-institutional company, the BOP endorsement is the practical floor. The mistake to avoid is assuming D&O alone covers employment claims - base D&O covers claims against directors and officers for management decisions, not the company's liability to its own employees, unless EPLI is specifically included.

Limits for a small-to-midsize life-sciences employer commonly run $1M-$3M, with a per-claim retention (deductible) the insured pays before coverage responds - often $10,000-$50,000 depending on size and state mix. Companies with California employees typically see higher retentions and premium because California claims cost more to defend.

Premium is driven by headcount, state footprint, layoff history, and prior claims more than by revenue. A small life-sciences employer with a clean history often sees EPLI in the low-to-mid four figures as a standalone or as an incremental cost inside a D&O program; a company with California exposure, recent reductions in force, or prior employment claims will see more. The defense-cost protection alone typically justifies the line well before a company reaches a size where an employment lawsuit would be survivable out of pocket.